01506nam 2200397Ia 450 991069884380332120120912142041.0(CKB)5470000002397428(OCoLC)326877876(EXLCZ)99547000000239742820090519d2006 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] considerations for developmental toxicity studies for preventive and therapeutic vaccines for infectious disease indicationsRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2006]i, 12 pages digital, PDF fileTitle from PDF title page (viewed on May 19, 2009)."February 2006".Includes bibliographical references (page 12).Guidance for industry Developmental toxicologyUnited StatesVaccinesUnited StatesEvaluationCommunicable diseasesPreventionDevelopmental toxicologyVaccinesEvaluation.Communicable diseasesPrevention.Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698843803321Guidance for industry3434577UNINA